|
|
Volumn 70, Issue 5, 2008, Pages 401-402
|
|
Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation
a
b
c
a,d
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METHOTREXATE;
ANTINEOPLASTIC ANTIMETABOLITE;
ARTICLE;
BRAIN RADIATION;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RELAPSE;
CANCER SURVIVAL;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG FATALITY;
DRUG MEGADOSE;
FOLLOW UP;
HUMAN;
KAPLAN MEIER METHOD;
MULTIPLE CYCLE TREATMENT;
PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
BRAIN TUMOR;
DISEASE FREE SURVIVAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
LYMPHOMA;
METHODOLOGY;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
RADIOTHERAPY;
SURVIVAL RATE;
TIME;
TUMOR RECURRENCE;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
BRAIN NEOPLASMS;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
KAPLAN-MEIERS ESTIMATE;
LYMPHOMA;
METHOTREXATE;
NEOPLASM RECURRENCE, LOCAL;
RADIOTHERAPY;
SURVIVAL RATE;
TIME;
TREATMENT OUTCOME;
|
|
EID: 39749162231
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000300671.37279.0e Document Type: Article |
|
Times cited : (74)
|
|
References (4)
|
